Tao Capital Management LP reported 6 positions worth $1.94B for the quarter ended Jun 30, 2026, up 1,532.6% on the prior quarter. It opened 1 new position, added to 1, trimmed 1 and exited 3. Its largest holding is Space Exploration Technologies Corp at 93.8% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Shares | Trade Value | Weight |
|---|---|---|---|
| SPCX Space Exploration Technologies Corp | +10.64M | $1.82B | 93.75% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | SPCX Space Exploration Technologies Corp | Industrials | 10.64M | $1.82B | 93.75% | +10.64M | – | New | 0.08% |
| 2 | TWST Twist Bioscience Corp | Healthcare | 478.8K | $49.26M | 2.54% | -350.0K | -42.2% | Reduced | 0.76% |
| 3 | TSLA Tesla, Inc. | Consumer Discretionary | 86.3K | $36.28M | 1.87% | 0 | 0.0% | Unchanged | 0% |
| 4 | H Hyatt Hotels Corp | Consumer Discretionary | 70.0K | $13.57M | 0.699% | 0 | 0.0% | Unchanged | 0.07% |
| 5 | MDGL Madrigal Pharmaceuticals, Inc. | Healthcare | 21.0K | $11.28M | 0.581% | 0 | 0.0% | Unchanged | 0.07% |
| 6 | TXG 10x Genomics, Inc. | Healthcare | 283.5K | $10.87M | 0.56% | +72.6K | +34.4% | Added | 0.22% |
Tip. Select a row to see that position’s full history at Tao Capital Management.
As of its Q2 2026 13F filing, Tao Capital Management LP’s five largest positions were Space Exploration Technologies Corp (SPCX) at 93.8%, Twist Bioscience Corp (TWST) at 2.5%, Tesla, Inc. (TSLA) at 1.9%, Hyatt Hotels Corp (H) at 0.7%, Madrigal Pharmaceuticals, Inc. (MDGL) at 0.6% of the reported portfolio.
Tao Capital Management LP reported a 13F portfolio worth $1.94B across 6 positions for Q2 2026. That is up 1,532.6% from the previous quarter.
Its largest purchases by value were Space Exploration Technologies Corp ($1.82B), 10x Genomics, Inc. ($2.78M). It opened 1 new positions.
Its largest sales by value were Twist Bioscience Corp ($36.01M), Ouster, Inc. ($15.53M), 908 Devices Inc. ($3.48M). It exited 3 positions entirely.
From the Form 13F-HR reports Tao Capital Management LP files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.